Moreover, a polymorphism of the enzyme glycine amidinotransferase (GATM or AGAT, the enzyme that catalyzes the first step in the synthesis of creatine) is associated with a reduced incidence of statin myopathy [40]. This evidence concerns the gene GATM and myopathy.